The Last Straw

Nanosonics (ASXNAN) First Half Results

Infection control company Nanosonics (ASX: NAN) today released its first half results for the 2020 Financial Year. Nanosonics sells the Trophon EPR device for disinfecting ultrasound probes, as well as the consumable capsules required for each disinfection cycle. This can be thought of as a razor + blade business model. The bad news was that profit before tax was down […]

Coronavirus: what does it mean for investors?

Fears over the impact of the worsening coronavirus outbreak continue to drive global markets sharply lower. And, potentially, things could get a lot worse from here. For the long term investor, it’s easy to deride such moves as mere ‘speed-bumps’ along an otherwise sure and prosperous road. Insert a Buffett quote, add a long term chart of market growth and […]

Vulcan makes zero carbon transportation possible

A global shift in capital allocations is underway. Trillions of dollars are flowing into sustainable or green investments, as the, ‘environmental, social and governance’ (ESG) sector shakes off its image as simply a feel-good investment class. New evidence demonstrates that profitability and environmental footprint are not mutually exclusive — but that ESG performance does in fact correlate with good financial […]

Pursuit Minerals pursues European nickel targets to meet growing battery metal demand

By 2025, 500,000 tonnes of refined nickel will be used annually in lithium-ion batteries for electric vehicles (EVs). This equates to a five-fold increase from the amount of nickel used in EVs in 2018. Seeking to capitalise on Europe’s rapidly expanding battery production capacity for both energy storage and use in electric vehicles, Pursuit Minerals (ASX:PUR) is taking steps to supply European […]

Creso Pharma (ASX:CPH) hits major medical cannabis milestones in human and animal health

The global legal marijuana market size is expected to reach US$66.3 billion by the end of 2025. Growth will be fuelled by increasing legalisation and the growing adoption of cannabis as a pharmaceutical product for treating severe medical conditions, such as cancer, Parkinson’s disease, Alzheimer’s disease, arthritis, and other neurological conditions. The US has already legalised medical marijuana in 33 states, with […]